Food and Drug
Administration
BLOOD PRODUCTS ADVISORY COMMITTEE
December 14, 2006
Slides
Overview of 21 CFR 50.24, Toby A. Silverman, M.D., OBRR, FDA (ppt) (htm)
Update of October 2006 Public Meeting on Emergency Research, Diane Maloney, J.D., FDA (ppt) (htm)
Overview of Hemoglobin-based Oxygen Carriers (HBOCs), Abdu I. Alayash, Ph.D., OBRR, FDA (ppt) (htm)
Introduction: Proposed Use of HBOC-201 in the RESUS (Restore Effective SUrvival in Shock, Laurence Landow, M.D., OBRR, FDA (ppt) (htm)
Sponsor Presentations, Dan Freilich, M.D., CDR, MC, USN, NMRC (ppt) (htm)
Sponsor Backup Slide, NMRC (ppt) (htm)
Studies of HBOC-201 in Animal Models of Hemorrhagic Shock, John R. Hess, M.D., Medical Director, Cancer Center Laboratory, Associate Director, Blood Bank, Department of Pathology, University of Maryland Medical School (ppt) (htm)
Studies of HBOC-201 in Animal Models of Hemorrhagic Shock, Thomas Hintze, Ph.D., Professor of Physiology, New York Medical College (ppt) (htm)
Studies of HBOC-201 in Animal Models of Hemorrhagic Shock, Carl Hauser, M.D., Visiting Professor of Surgery, Beth Israel Deaconess Medical Center (ppt) (htm)
FDA Presentation to BPAC: NMRC RESUS Protocol Using HBOC-201, Toby Silverman, M.D., OBRR, FDA (ppt) (htm)
Up
| AC Home Page